<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="iso-abbrev">Braz J Cardiovasc Surg</journal-id><journal-id journal-id-type="publisher-id">rbccv</journal-id><journal-title-group><journal-title>Brazilian Journal of Cardiovascular Surgery</journal-title></journal-title-group><issn pub-type="ppub">0102-7638</issn><issn pub-type="epub">1678-9741</issn><publisher><publisher-name>Sociedade Brasileira de Cirurgia Cardiovascular</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29898146</article-id><article-id pub-id-type="pmc">5985843</article-id><article-id pub-id-type="doi">10.21470/1678-9741-2017-0152</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Outcomes After Surgical Resection of Primary Non-Myxoma Cardiac
Tumors</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Boyac&#x00131;o&#x0011f;lu</surname><given-names>Kamil</given-names></name><xref ref-type="aff" rid="aff1">1</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Ak</surname><given-names>Adnan</given-names></name><xref ref-type="aff" rid="aff2">2</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>D&#x000f6;nmez</surname><given-names>Arzu Antal</given-names></name><xref ref-type="aff" rid="aff2">2</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>&#x000c7;ayhan</surname><given-names>Bur&#x000e7;in</given-names></name><xref ref-type="aff" rid="aff2">2</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Aks&#x000fc;t</surname><given-names>Mehmet</given-names></name><xref ref-type="aff" rid="aff2">2</xref><role>MD</role></contrib><contrib contrib-type="author"><name><surname>Tun&#x000e7;er</surname><given-names>Mehmet Altu&#x0011f;</given-names></name><xref ref-type="aff" rid="aff2">2</xref><role>MD, PhD</role></contrib></contrib-group><aff id="aff1"><label>1</label> Cardiovascular Surgery Department, Bagcilar Research and
Training Hospital, Istanbul, Turkey.</aff><aff id="aff2"><label>2</label> Kartal Ko&#x0015f;uyolu Research and Training Hospital,
Cardiovascular Surgery Department, Istanbul, Turkey.</aff><author-notes><corresp id="c1">Correspondence Address: Kamil Boyacioglu, Bagcilar Research and
Training Hospital, Cardiovascular Surgery Department, Istanbul, Turkey. Bagcilar
Research and Training Hospital, Cardiovascular Surgery Department, Merkez Mah.
6. Sok. 34200 Bagcilar - Istanbul, Turkey. Email:
<email>kamilboyacioglu@yahoo.com.tr</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>Mar-Apr</season><year>2018</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Mar-Apr</season><year>2018</year></pub-date><volume>33</volume><issue>2</issue><fpage>162</fpage><lpage>168</lpage><history><date date-type="received"><day>22</day><month>7</month><year>2017</year></date><date date-type="accepted"><day>26</day><month>9</month><year>2017</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><sec><title>Objective</title><p>Primary cardiac tumors are rare lesions with different histological type. We
reviewed our 17 years of experience in the surgical treatment and clinical
results of primary non-myxoma cardiac tumors.</p></sec><sec><title>Methods</title><p>Between July 2000 and February 2017, 21 patients with primary cardiac tumor
were surgically treated in our institution. The tumors were categorized as
benign non-myxomas and malignants. Data including the demographic
characteristics, details of the tumor histology and grading, cardiac medical
and surgical history, surgical procedure of the patients were obtained from
the hospital database.</p></sec><sec><title>Results</title><p>Eleven patients were diagnosed with benign non-myxoma tumor
(male/female:7/4), ranging in age from 10 days to 74 years (mean age
30.9&#x000b1;26.5 years). Papillary &#x0fb01;broelastoma was the most frequent type
(63.6%). There were two early deaths in benign group (all were rhabdomyoma),
and mortality rate was 18%. The mean follow-up period was 69.3&#x000b1;58.7
months (range, 3 to 178 months). All survivals in benign group were free of
tumor-related symptoms and tumor relapses. Ten patients were diagnosed with
malignant tumor (sarcoma/lymphoma:8/2, male/female:3/7), ranging in age from
14 years to 73 years (mean age 44.7&#x000b1;18.9 years). Total resection
could be done in only three (30%) patients. The mean follow-up period was
18.7&#x000b1;24.8 months (range, 0-78 months). Six patients died in the first
10 months.</p></sec><sec><title>Conclusion</title><p>Complete resection of the cardiac tumors, whenever possible, is the main goal
of surgery. Surgical resection of benign cardiac tumors is safe, usually
curative and provides excellent long-term prognosis. On the contrary,
malignant cardiac tumors still remain highly lethal.</p></sec></abstract><kwd-group><kwd>Heart Neoplasm</kwd><kwd>Cardiovascular Surgical Procedures</kwd><kwd>Treatment Outcome</kwd></kwd-group></article-meta></front><body><table-wrap id="t5" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="10%" span="1"/><col width="90%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" style="background-color:#e6e7e8" rowspan="1">Abbreviations,
acronyms &#x00026; symbols</th></tr></thead><tbody><tr><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">TTE</td><td align="left" style="background-color:#e6e7e8" rowspan="1" colspan="1">= Transthoracic
echocardiogram</td></tr></tbody></table></table-wrap><sec sec-type="intro"><title>INTRODUCTION</title><p>Cardiac tumors can be categorized as primary or secondary, depending on the origins
of the tumors. Metastatic malignant heart tumors are nearly 50 times more common
than primary cardiac tumors<sup>[<xref rid="r1" ref-type="bibr">1</xref>]</sup>. The presence of primary cardiac tumors is rare with
an overall incidence rate of &#x0003c; 0.33%. Approximately 75% of the primary cardiac
tumors are benign; the most common histopathological type is myxoma in 50% of the
cases, followed by papillary fibroelastomas, fibromas, lipomas, rhabdomyomas,
hemangiomas and teratomas<sup>[<xref rid="r2" ref-type="bibr">2</xref>]</sup>. Cardiac sarcoma represents the primary malignant
tumors of the heart. Lymphoma can also affect the heart,
primarily<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup>. The symptoms of the tumors are non specific and can
mimic many other cardiac diseases.</p><p>In this study, we reviewed our 17 years of experience in the surgical treatment and
clinical results of primary non-myxoma cardiac tumors.</p></sec><sec sec-type="methods"><title>METHODS</title><p>Between July 2000 and February 2017, 21 patients with primary cardiac tumors were
surgically treated in our institution and 11 of these were diagnosed with primary
benign cardiac tumors. Patients with tumors metastatic to the heart and those in
whom a primary cardiac origin was not clear were excluded from the study. Data
including the demographic characteristics, details of the tumor histology and
grading, cardiac medical and surgical history, surgical procedure of the patients
were obtained from the hospital database. Preoperative diagnosis was established
using transthoracic echocardiogram (TTE). Coronary angiography and computed
tomography were performed in eight (38%) and three (14%) patients, respectively.
Annual TTEs were performed during follow-up to evaluate the left ventricular
function, presence of intracardiac masses, filling status and valve function after
tumor resection. Patients were interviewed over the phone to assess late functional
status. Statistical analyses were performed using the statistical software SPSS 15.0
for Windows (SPSS Inc, Chicago, IL, USA). Pearson chi-square test was used for
comparisons between the pediatric and adult patients. Survival was estimated using
the Kaplan-Meier product limit method and curves were compared using a log-rank
test. A <italic>P</italic>-value &#x0003c;0.05 was considered statistically
significant.</p><p>For reporting purposes, the tumors were grouped into two categories: benign
non-myxomas and malignant.</p><p>The study protocol was approved by the Kartal Ko&#x0015f;uyolu Research and Training
Hospital Ethics Committee. Written informed consents were obtained from each patient
or parents, in case of pediatric patients. The study was conducted in accordance
with the principles of the Declaration of Helsinki. The authors had full access to
all of the data in this study and take full responsibility for the integrity of the
data. All authors have read and agreed with the manuscript.</p></sec><sec sec-type="results"><title>RESULTS</title><p>Benign non-myxoma tumors represent 52% of the total patient cohort, seven (64%)
patients were male and four (36%) were female, ranging in age from 10 days to 74
years (mean age 30.9&#x000b1;26.5 years). Seven patients had papillary &#x0fb01;broelastomas
and other pathology as delineated in <xref ref-type="table" rid="t1">Table 1</xref>.
There was a female predominance (female/male:7/3) in patients with malignant tumors
and they were ranging in age from 14 years to 73 years (mean age 44.7&#x000b1;18.9
years). Two patients had primary cardiac lymphomas and rest had different kinds of
sarcomas (<xref ref-type="table" rid="t1">Table 1</xref>).</p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Histopathologic types of tumors.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="50%" span="1"/><col width="50%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Histology</th><th align="center" rowspan="1" colspan="1">Number of patients</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Benign</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Papillary fibroelastoma</td><td align="center" rowspan="1" colspan="1">7</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Rhabdomyoma</td><td align="center" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Fibroma</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Angiomatosis</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">Malignant</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Angiosarcoma</td><td align="center" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Leomyosarcoma</td><td align="center" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Rhabdomyosarcoma</td><td align="center" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Fibrosarcoma</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Sarcoma</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;T cell lymphoma</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;B cell lymphoma</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">Total</td><td align="center" rowspan="1" colspan="1">21</td></tr></tbody></table></table-wrap><p>The symptoms, surgical procedures and follow-up periods of all patients in both
groups are summarized in <xref ref-type="table" rid="t2">Tables 2</xref> and <xref ref-type="table" rid="t3">3</xref>. Dyspnea and palpitation were the most
frequent symptoms. Although some patients with papillary fibroelastoma were
asymptomatic in benign group, there were various grades of symptoms in all of the
malignant types.</p><table-wrap id="t2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Clinical findings, surgical procedures and follow-up of benign non-myxoma
cardiac tumors.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="2%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">&#x000a0;</th><th align="center" rowspan="1" colspan="1">Age/Gender</th><th align="center" rowspan="1" colspan="1">Symptoms</th><th align="center" rowspan="1" colspan="1">Pathology/Size</th><th align="center" rowspan="1" colspan="1">Location</th><th align="center" rowspan="1" colspan="1">Approach</th><th align="center" rowspan="1" colspan="1">Surgery</th><th align="center" rowspan="1" colspan="1">Survey/Follow-up</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">28 years, M</td><td align="center" rowspan="1" colspan="1">Angina</td><td align="center" rowspan="1" colspan="1">Papillary fibroelastoma/1x1 cm</td><td align="center" rowspan="1" colspan="1">AV</td><td align="center" rowspan="1" colspan="1">Aortotomy</td><td align="center" rowspan="1" colspan="1">Resection</td><td align="center" rowspan="1" colspan="1">Survived/3 months</td></tr><tr><td align="left" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">74 years, M</td><td align="center" rowspan="1" colspan="1">Asymptomatic</td><td align="center" rowspan="1" colspan="1">Papillary fibroelastoma/1x1.2 cm</td><td align="center" rowspan="1" colspan="1">AV</td><td align="center" rowspan="1" colspan="1">Aortotomy</td><td align="center" rowspan="1" colspan="1">Resection, aortic repair</td><td align="center" rowspan="1" colspan="1">Survived/3 months</td></tr><tr><td align="left" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">28 years, M</td><td align="center" rowspan="1" colspan="1">Palpitation</td><td align="center" rowspan="1" colspan="1">Papillary fibroelastoma/1x1.5cm</td><td align="center" rowspan="1" colspan="1">MV posterior leaflet</td><td align="center" rowspan="1" colspan="1">Right atriotomy, transseptal left atriotomy</td><td align="center" rowspan="1" colspan="1">Resection</td><td align="center" rowspan="1" colspan="1">Survived/35 months</td></tr><tr><td align="left" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">67 years, M</td><td align="center" rowspan="1" colspan="1">Dyspnea, angina</td><td align="center" rowspan="1" colspan="1">Papillary fibroelastoma/1.5x1.5 cm</td><td align="center" rowspan="1" colspan="1">TV posterior leaflet</td><td align="center" rowspan="1" colspan="1">Right atriotomy</td><td align="center" rowspan="1" colspan="1">Resection, tricuspid repair, CABG</td><td align="center" rowspan="1" colspan="1">Survived/38 months</td></tr><tr><td align="left" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">9 years, F</td><td align="center" rowspan="1" colspan="1">Asymptomatic</td><td align="center" rowspan="1" colspan="1">Papillary fibroelastoma/1x1 cm</td><td align="center" rowspan="1" colspan="1">MV papillary muscle</td><td align="center" rowspan="1" colspan="1">Left and right atriotomy</td><td align="center" rowspan="1" colspan="1">Resection, PFO repair</td><td align="center" rowspan="1" colspan="1">Survived/51 months</td></tr><tr><td align="left" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">52 years, F</td><td align="center" rowspan="1" colspan="1">Dyspnea</td><td align="center" rowspan="1" colspan="1">Papillary fibroelastoma/1x1 cm</td><td align="center" rowspan="1" colspan="1">MV papillary muscle</td><td align="center" rowspan="1" colspan="1">Left atriotomy</td><td align="center" rowspan="1" colspan="1">Resection, mitral ring annuloplasty</td><td align="center" rowspan="1" colspan="1">Survived/119 months</td></tr><tr><td align="left" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">51 years, F</td><td align="center" rowspan="1" colspan="1">Asymptomatic</td><td align="center" rowspan="1" colspan="1">Papillary fibroelastoma/1x1 cm</td><td align="center" rowspan="1" colspan="1">AV</td><td align="center" rowspan="1" colspan="1">Aortotomy</td><td align="center" rowspan="1" colspan="1">Resection, aortic repair</td><td align="center" rowspan="1" colspan="1">Survived/178 months</td></tr><tr><td align="left" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">1 month, M</td><td align="center" rowspan="1" colspan="1">Dyspnea</td><td align="center" rowspan="1" colspan="1">Rhabdomyoma/4x4 cm</td><td align="center" rowspan="1" colspan="1">RVOT</td><td align="center" rowspan="1" colspan="1">Right atriotomy and right ventriculotomy</td><td align="center" rowspan="1" colspan="1">Complete resection, RV&#x000a0; patch repair</td><td align="center" rowspan="1" colspan="1">Died /postoperative day 1</td></tr><tr><td align="left" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">10 days, M</td><td align="center" rowspan="1" colspan="1">Dyspnea, cyanosis</td><td align="center" rowspan="1" colspan="1">Rhabdomyoma/4x5 cm</td><td align="center" rowspan="1" colspan="1">LV</td><td align="center" rowspan="1" colspan="1">__</td><td align="center" rowspan="1" colspan="1">&#x00130;ncomplete resection</td><td align="center" rowspan="1" colspan="1">Died/2 months</td></tr><tr><td align="left" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">5 years, F</td><td align="center" rowspan="1" colspan="1">Dyspnea, palpitation</td><td align="center" rowspan="1" colspan="1">Fibroma/5.5x3 cm</td><td align="center" rowspan="1" colspan="1">LV</td><td align="center" rowspan="1" colspan="1">__</td><td align="center" rowspan="1" colspan="1">Complete resection</td><td align="center" rowspan="1" colspan="1">Survived/112 months</td></tr><tr><td align="left" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">25 years, M</td><td align="center" rowspan="1" colspan="1">Palpitation, syncope</td><td align="center" rowspan="1" colspan="1">Angiomatosis/5x5 cm</td><td align="center" rowspan="1" colspan="1">LV</td><td align="center" rowspan="1" colspan="1">Left ventriculotomy</td><td align="center" rowspan="1" colspan="1">Complete resection</td><td align="center" rowspan="1" colspan="1">Survived/85 months</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p>AV=aortic valve; CABG=coronary artery bypass surgery; F=female; LV=left
ventricle; M=male; MV=mitral valve; PFO=patent foramen ovale; RVOT=right
ventricle outflow tract; TV=tricuspid valve</p></fn></table-wrap-foot></table-wrap><table-wrap id="t3" orientation="portrait" position="float"><label>Table 3</label><caption><p>Clinical findings, surgical procedures and follow-up of malignant cardiac
tumors.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="2%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/><col width="14%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">&#x000a0;</th><th align="center" rowspan="1" colspan="1">Age/ Gender</th><th align="center" rowspan="1" colspan="1">Symptoms</th><th align="center" rowspan="1" colspan="1">Pathology/Size</th><th align="center" rowspan="1" colspan="1">Location</th><th align="center" rowspan="1" colspan="1">Approach</th><th align="center" rowspan="1" colspan="1">Surgery</th><th align="center" rowspan="1" colspan="1">Survey/Follow-up</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">43 years, F</td><td align="center" rowspan="1" colspan="1">Dyspnea, palpitation</td><td align="center" rowspan="1" colspan="1">Rhabdomyosarcoma/ 6x5 cm</td><td align="center" rowspan="1" colspan="1">LA</td><td align="center" rowspan="1" colspan="1">Left and right atriotomy</td><td align="center" rowspan="1" colspan="1">Incomplete resection</td><td align="center" rowspan="1" colspan="1">Died/9 months</td></tr><tr><td align="left" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">73 years, F</td><td align="center" rowspan="1" colspan="1">Palpitation,dsypnea, T&#x00130;A</td><td align="center" rowspan="1" colspan="1">Rhabdomyosarcoma/ 2x2 cm</td><td align="center" rowspan="1" colspan="1">LA</td><td align="center" rowspan="1" colspan="1">Left and right atriotomy</td><td align="center" rowspan="1" colspan="1">Complete resection, mitral ring annuloplasty</td><td align="center" rowspan="1" colspan="1">Died/3 months</td></tr><tr><td align="left" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">30 years, F</td><td align="center" rowspan="1" colspan="1">Dyspnea</td><td align="center" rowspan="1" colspan="1">Leomyosarcoma/ 3x5 cm</td><td align="center" rowspan="1" colspan="1">RA, RV, RVOT</td><td align="center" rowspan="1" colspan="1">Right atriotomy</td><td align="center" rowspan="1" colspan="1">Incomplete resection (reoperation at 30<sup>th</sup>
and 39<sup>th</sup> months)</td><td align="center" rowspan="1" colspan="1">Died/43 months</td></tr><tr><td align="left" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">49 years, F</td><td align="center" rowspan="1" colspan="1">Dyspnea, palpitation</td><td align="center" rowspan="1" colspan="1">Leomyosarcoma/ 7x8 cm</td><td align="center" rowspan="1" colspan="1">LA</td><td align="center" rowspan="1" colspan="1">Left atriotomy</td><td align="center" rowspan="1" colspan="1">Complete resection, mitral valve repair</td><td align="center" rowspan="1" colspan="1">Died/ 28 months</td></tr><tr><td align="left" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">23 years, M</td><td align="center" rowspan="1" colspan="1">Dyspnea, palpitation, syncope</td><td align="center" rowspan="1" colspan="1">Angiosarcoma/ 8x9 cm</td><td align="center" rowspan="1" colspan="1">RA, RV</td><td align="center" rowspan="1" colspan="1">Right atriotomy</td><td align="center" rowspan="1" colspan="1">Incomplete resection</td><td align="center" rowspan="1" colspan="1">Died/5 months</td></tr><tr><td align="left" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">47 years, F</td><td align="center" rowspan="1" colspan="1">Dyspnea, syncope</td><td align="center" rowspan="1" colspan="1">Angiosarcoma/ 10x4 cm</td><td align="center" rowspan="1" colspan="1">RA</td><td align="center" rowspan="1" colspan="1">Right atriotomy</td><td align="center" rowspan="1" colspan="1">Complete resection, TDVA, CABG</td><td align="center" rowspan="1" colspan="1">Survived/10 months-NED</td></tr><tr><td align="left" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">62 years, F</td><td align="center" rowspan="1" colspan="1">Dyspnea, palpitation, peripheral edema</td><td align="center" rowspan="1" colspan="1">Fibrosarcoma/9x6.5 cm</td><td align="center" rowspan="1" colspan="1">RV, PA</td><td align="center" rowspan="1" colspan="1">Right ventriculotomy, pulmonary arteriotomy</td><td align="center" rowspan="1" colspan="1">Incomplete resection, pulmonary endarterectomy</td><td align="center" rowspan="1" colspan="1">Died/ postoperative&#x000a0; day 5</td></tr><tr><td align="left" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">40 years, F</td><td align="center" rowspan="1" colspan="1">Dyspnea, palpitation, peripheral edema</td><td align="center" rowspan="1" colspan="1">Sarcoma/7x3 cm</td><td align="center" rowspan="1" colspan="1">LA, LV</td><td align="center" rowspan="1" colspan="1">Left and right atriotomy, aortotomy</td><td align="center" rowspan="1" colspan="1">Incomplete resection</td><td align="center" rowspan="1" colspan="1">Died/10 months</td></tr><tr><td align="left" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">14 years, M</td><td align="center" rowspan="1" colspan="1">Dyspnea, palpitation</td><td align="center" rowspan="1" colspan="1">T cell lymphoma/ 6x8 cm</td><td align="center" rowspan="1" colspan="1">SVC, aorta, pulmonary artery</td><td align="center" rowspan="1" colspan="1">___</td><td align="center" rowspan="1" colspan="1">Incomplete resection</td><td align="center" rowspan="1" colspan="1">Survived/78 months-NED</td></tr><tr><td align="left" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">66 years, M</td><td align="center" rowspan="1" colspan="1">Dyspnea</td><td align="center" rowspan="1" colspan="1">B cell lymphoma/ 9x9.5 cm</td><td align="center" rowspan="1" colspan="1">RA, RV</td><td align="center" rowspan="1" colspan="1">Right atriotomy</td><td align="center" rowspan="1" colspan="1">Incomplete resection</td><td align="center" rowspan="1" colspan="1">Died/1 month</td></tr></tbody></table><table-wrap-foot><fn id="TFN2"><p>CABG=coronary artery bypass surgery; F=female; LA=left atrium; LV=left
ventricle; M=male; NED=no evidence of disease; PA=pulmonary artery;
RA=right atrium; RV=right ventricle; RVOT=right ventricle outflow tract;
SVC=superior vena cava; TDVA=tricuspid De Vega annuloplasty</p></fn></table-wrap-foot></table-wrap><p>There were five pediatric patients in the entire group and four of these patients had
benign tumors (<xref ref-type="table" rid="t4">Table 4</xref>). As seen on <xref ref-type="table" rid="t4">Table 4</xref>, although malignant primary cardiac
tumors appeared almost exclusively in adults in our patients, no statistically
significant difference between the pediatric and adult patients could be observed
(<italic>P</italic>=0.157). The details of tumor types in pediatric patients are
shown in <xref ref-type="table" rid="t2">Tables 2</xref> and <xref ref-type="table" rid="t3">3</xref>.</p><table-wrap id="t4" orientation="portrait" position="float"><label>Table 4</label><caption><p>The distribution of the tumor types according to age groups.</p></caption><table frame="hsides" rules="all"><colgroup span="1"><col width="25%" span="1"/><col width="25%" span="1"/><col width="25%" span="1"/><col width="25%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">&#x000a0;</th><th align="center" rowspan="1" colspan="1">Benign tumors (n=11)</th><th align="center" rowspan="1" colspan="1">Malignant tumors (n=10)</th><th align="center" rowspan="1" colspan="1"><italic>P</italic></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Pediatric patients</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">0.157</td></tr><tr><td align="left" rowspan="1" colspan="1">Adult patients</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr></tbody></table></table-wrap><p>Three patients suffered from mitral valve regurgitation, one patient had severe
anterior descending artery stenosis, right ventricular out&#x0fb02;ow tract obstruction
occurred in one patient, and patent foramen ovale was present in one patient. Two
patients had previous extracardiac malignancy: gastric lymphoma and fibrosarcoma in
abdomen (patient 1 in malignant, patient 4 in benign group, respectively).</p><p>Resection of the cardiac tumors was performed through a median sternotomy with
cardiopulmonary bypass in all patients except three: patient 9 in benign, and
patients 5 and 9 in malignant group. In all three patients palliative resection was
performed as much as possible and chemotherapy was administered after surgery.
Ascending aortic arterial and bicaval venous cannulation was the standard technique
with moderate systemic hypothermia (30&#x000ba;-32&#x000ba;C). In patients with aortic papillary
fibroelastoma two-stage venous cannulation was done and in one patient with
fibrosarcoma total circulatory arrest was required for the resection of the tumor
invading pulmonary artery branches. Both pediatric patients with rhabdomyoma
underwent emergency surgery because of the right ventricular outflow tract
obstruction (patient 8) and congestive heart failure with severe cyanosis (patient
9). The latter patient had hypoplasia of the left lung and only palliative resection
could be done without the use of cardiopulmonary bypass. In one patient in malignant
group with unclassified sarcoma diagnosis (patient 8), emergent surgery was required
due to the presence of pulmonary edema. With the rest of the patients, operations
were undertaken on an urgent basis (within one week). In benign group, entire tumor
mass could be resected completely except for one (91%) patient, but in malignant
group total resection could be done in only three (30%) patients. Associated
procedures: three mitral valve annuloplasties, two tricuspid valve annuloplasties
(De Vega and bicuspidization technique), two coronary artery bypass grafts (due to
the complete resection of angiosarcoma that has spread around the right coronary
artery route in patient 6), two aortic valve repairs and one patent foramen ovale
repair.</p><p>Mean cardiopulmonary bypass time was 73.4&#x000b1;55.1 min and mean myocardial
ischemic time was 35.2&#x000b1;11 min in benign group. Those times were
107.6&#x000b1;55 min and 74.3&#x000b1;44.6 min in malignant group, respectively. Mean
duration of hospital stay was 6.5&#x000b1;1.5 days and mean mechanical ventilation
time was 5.7&#x000b1;2.8 h in benign group and these times were 10.2&#x000b1;4.9 days
and 11&#x000b1;6.2 h. in malignant group, respectively.</p><p>Arrhythmia was observed in two patients in malignant group (patient 4 and 8) after
surgery. One patient suffered from pneumonia in postoperative period (patient 2 in
malignant group). Postoperative bleeding occurred in three patients. Drainage was
successfully managed medically in the patient with T-cell lymphoma, but the other
two were needed re-exploration (patient 2 in benign, patient 7 in malignant group).
Extracorporeal membrane oxygenation and high-dose inotropic support was required in
the postoperative period due to low-cardiac output after the resection of a large,
right ventricular and pulmonary arterial fibrosarcoma in one patient (patient
7).</p><p>Two of the deceased patients had benign tumors (all were rhabdomyoma) and eight had
malignant tumors with postoperative mortality rates of 18% and 80%,
respectively.</p><p>All survivals in benign group were free of tumor-related symptoms and tumor relapses
or any progression. No patient in this group required reoperation for tumor related
or any other cardiac problem. The mean follow-up period was 69.3&#x000b1;58.7 months
(range, 3 to 178 months). Two patients with sarcoma had evidence of metastatic
disease after surgery (patient 4- lung, patient 7- liver). One patient required
reoperation in the 30<sup>th</sup> and 39<sup>th</sup> months during the follow-up
period (<xref ref-type="table" rid="t3">Table 3</xref>). The patient with T-cell
lymphoma had complete remission after the chemotherapy. He is now 20 years old with
no evidence of lymphoma in any screening modalities. The other survived patient with
angiosarcoma has no tumor-related clinical manifestation. She is receiving
chemotheraphy with anthracycline and ifosfamide. The mean follow-up period for the
entire group was 18.7&#x000b1;24.8 months (range, 0-78 months). Six patients died in
the first 10 months. The cumulative survival rates are shown in <xref ref-type="fig" rid="f1">Figure 1</xref> and this finding was statistically significant
(<italic>P</italic>=0.017 by log-rank test). In pediatric patients, there were
two early deaths, one patient were diagnosed with rhabdomyoma and the other three
patients are still alive without any complaints associated with the tumors. In <xref ref-type="fig" rid="f2">Figure 2</xref>, the cumulative survival rates between
the pediatric and adult patients are shown and no statistically significant
difference was observed (<italic>P</italic>=0.717 by log-rank test).</p><p>
<fig id="f1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Survival curves of patients with benign non-myxoma (blue) versus malign
cardiac tumors (green) demonstrate an inferior survival for patients
with malign tumors (P=0.017).</p></caption><graphic xlink:href="rbccv-33-02-0162-g01"/></fig>
</p><p>
<fig id="f2" orientation="portrait" position="float"><label>Fig. 2</label><caption><p>Survival curves between the pediatric (blue) and adult (green) patients.
No statistically significant difference between the groups was observed
(P=0.717).</p></caption><graphic xlink:href="rbccv-33-02-0162-g02"/></fig>
</p></sec><sec sec-type="discussion"><title>DISCUSSION</title><p>Despite the widespread use of echocardiography, primary cardiac tumors remain an
uncommon occurrence. Myxomas are con&#x0fb01;rmed to be the most frequent cardiac tumors and
once they are excluded, the other types of cardiac tumors are extremely rare. After
surgical resection, the main difference between benign and malignant tumors is the
survival rates<sup>[<xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r4" ref-type="bibr">4</xref>]</sup>. In our series, surgical resection of primary benign
cardiac tumors has good short and long term results; conversely the prognosis of
malignant types is poor.</p><p>Rhabdomyomas are the most frequent primary cardiac tumor in infants and children and
are usually discovered in patients less than one year of age<sup>[<xref rid="r5" ref-type="bibr">5</xref>]</sup>. These tumors are benign
myocardial hamartomas which usually display no significant symptoms and tends to
regress spontaneously. Thus, most patients without any hemodynamic abnormalities or
intractable arrhythmias do not require routine surgery. Moreover, total resection of
the tumor may not be always possible due to the pathologic characteristic of
rhabdomyomas: they are intramural masses and most commonly multiple in number with
intracavitary extensions<sup>[<xref rid="r6" ref-type="bibr">6</xref>]</sup>. In our patients, both had severe hemodynamic
instability and total resection could be performed in only one patient, but both
died after surgery in the early period. Although the number of patients in the
different studies is not sufficient, mortality rates vary between
3-21%<sup>[<xref rid="r5" ref-type="bibr">5</xref>,<xref rid="r7" ref-type="bibr">7</xref>]</sup>.</p><p>Papillary fibroelastomas are the most frequent cardiac valvular tumor. Although there
are many hypotheses, the etiology is still unclear<sup>[<xref rid="r8" ref-type="bibr">8</xref>]</sup>. They are usually
solitary, less than 1.5 cm in diameter, and diagnosed in older patients. As with our
patients, sometimes they can be encountered in children and young
adults<sup>[<xref rid="r7" ref-type="bibr">7</xref>,<xref rid="r9" ref-type="bibr">9</xref>]</sup>. There is no gender predominance. Most papillary
fibroelastomas are asymptomatic and found incidentally, however, affected patients
may present with thromboembolic events such as transient ischemic attacks or stroke,
chest pain or sudden death secondary to the obstruction of coronary arteries and
peripheral embolism<sup>[<xref rid="r8" ref-type="bibr">8</xref>,<xref rid="r10" ref-type="bibr">10</xref>]</sup>. These tumor related embolic events and death are
associated with mobility of the tumor not with its size<sup>[<xref rid="r11" ref-type="bibr">11</xref>]</sup>. The surgical
resection is curative and long-term prognosis after surgery is
excellent<sup>[<xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r11" ref-type="bibr">11</xref>]</sup>.</p><p>Cardiac fibromas typically occur in childhood period. These tumors are solitary and
usually arise from left ventricle as in our case. They may invade the ventricle
muscles and the conduction system, therefore they can cause the congestive heart
failure and refractory ventricular arrhythmias. Surgery is usually indicated because
spontaneous regression has never been observed and surgical outcome is successful in
most of the patients whether total or partial resection has been done with freedom
from recurrence<sup>[<xref rid="r12" ref-type="bibr">12</xref>]</sup>.</p><p>Hemangiomas and lymphangiomas are major vascular cardiac tumors. Angiomatosis is
quite a rare vascular tumor and is usually observed during childhood. Primary left
ventricular angiomatosis was first described in our patient<sup>[<xref rid="r13" ref-type="bibr">13</xref>]</sup>. They may cause
ventricular tachycardia and presyncopal attacks. The tumor was capsulated, yellowish
and rubbery in our case. During the follow-up period, no recurrence or relapse or
any other hemodynamic concerns were encountered.</p><p>Approximately 10% of cardiac tumors which are surgically resected are primary
sarcomas. Sarcomas are malignant mesenchymal tumors. Angiosarcomas are the most
common type of primary cardiac sarcomas<sup>[<xref rid="r14" ref-type="bibr">14</xref>]</sup>. Although they can involve all of the
cardiac chambers, angiosarcomas tend to arise from the right atrium, the other types
of sarcomas more commonly affect the left side of the heart. Patients can present
with similar symptoms as the other cardiovascular diseases: dyspnea (the most
frequent symptom), palpitation, chest pain, congestive heart failure, pericardial
effusion or cardiac tamponade. Today, after the diagnosis of cardiac sarcoma to be
established, patients undergo a thorough review by a multidisciplinary cardiac tumor
team, including medical and radiation oncologists, cardiologists, radiologists and
cardiac surgeons. Multiple imaging modalities including echocardiography, computed
tomography, cardiac magnetic resonance imaging, total body positron emission
tomography, coronary angiography are utilized to assess the cardiac structures,
tumor resectability and intra- or extrathoracic metastases and to plan the
treatment<sup>[<xref rid="r15" ref-type="bibr">15</xref>,<xref rid="r16" ref-type="bibr">16</xref>]</sup>. Treatment consists of neoadjuvant chemotherapy,
radical surgery and adjuvant chemo- and radiation therapy. Primary cardiac sarcomas
possess the highly aggressive local growth and metastatic spreads are common. The
prognosis for patients with cardiac sarcomas remains very poor. Survival rates are
primarily related with tumor histology, complete or incomplete resection and distant
organ metastasis at presentation<sup>[<xref rid="r14" ref-type="bibr">14</xref>,<xref rid="r17" ref-type="bibr">17</xref>]</sup>. Some authors classified the cardiac sarcoma by
their anatomic location rather than by histopathologic type: right heart sarcomas,
left heart sarcomas, pulmonary artery sarcomas<sup>[<xref rid="r15" ref-type="bibr">15</xref>,<xref rid="r16" ref-type="bibr">16</xref>,<xref rid="r18" ref-type="bibr">18</xref>]</sup>. Right heart sarcomas tend to be bulky,
infiltrative and metastasize early and neoadjuvant chemotherapy can reduce the tumor
size thus increase the possibility of success a total resection; in contrast, left
heart sarcomas typically presenting with locally advanced tumor and cardiac
autotransplantation technique may enable the optimal exposure for complete resection
and cardiac reconstruction in complex left sided tumors<sup>[<xref rid="r18" ref-type="bibr">18</xref>,<xref rid="r19" ref-type="bibr">19</xref>]</sup>. Pulmonary artery
sarcoma tends to be angiosarcoma and present with symptoms related to pulmonary
artery obstruction associated with intraluminal growth and spread. This
classification influence the prognosis and treatment strategy rather than by
histological type<sup>[<xref rid="r15" ref-type="bibr">15</xref>,<xref rid="r16" ref-type="bibr">16</xref>,<xref rid="r20" ref-type="bibr">20</xref>]</sup>. Furthermore, neoadjuvant and/or adjuvant
chemotherapies have been reported to achieve prolonged survival rates in certain
cases<sup>[<xref rid="r15" ref-type="bibr">15</xref>,<xref rid="r16" ref-type="bibr">16</xref>,<xref rid="r20" ref-type="bibr">20</xref>]</sup>.</p><p>Primary cardiac lymphoma is an extremely rare subset of non-Hodgkin's lymphoma,
involving only the heart and/or the pericardium. The majority of cardiac lymphomas
are B-cell neoplasms<sup>[<xref rid="r21" ref-type="bibr">21</xref>]</sup>. T-cell lymphoma was found in only 5% of all
primary cardiac lymphoma types in a large literature review<sup>[<xref rid="r22" ref-type="bibr">22</xref>]</sup>. These tumors
generally involve the right heart and the right atrium is the cardiac chamber most
affected by primary cardiac lymphoma<sup>[<xref rid="r3" ref-type="bibr">3</xref>]</sup>. Lymphoma may appear isolated in the mitral
valve<sup>[<xref rid="r23" ref-type="bibr">23</xref>]</sup>. In our cases, one of them arose from the right
atrium and ventricle, and the other originated from the superior vena cava. The
latter has spread to the aorta and pulmonary artery. Dyspnea is the most common
presenting symptom in the primary cardiac sarcomas. The most common treatment
modality is chemotherapy and the surgical resection is required almost 30% of
patients<sup>[<xref rid="r22" ref-type="bibr">22</xref>]</sup>. The prognosis of primary cardiac lymphomas is
better than the cardiac sarcomas in treated patients and surgery accompanied by
chemotherapy has good outcomes<sup>[<xref rid="r24" ref-type="bibr">24</xref>,<xref rid="r25" ref-type="bibr">25</xref>]</sup>. Immunodeficiency, extracardiac disease, left
ventricular involvement, and the absence of arrhythmias have adverse effect on
prognosis<sup>[<xref rid="r22" ref-type="bibr">22</xref>]</sup>.</p><sec><title>Limitation</title><p>The findings of a retrospective study of patients that underwent surgical
resection of primary non-myxoma cardiac tumors were presented. The major
limitation of this study was its small sample size in both benign and malignant
groups because of the rarity of these tumors. Moreover, we could only perform
palliative surgery in most of the patients in the malignant group and so the
prognostic significance between complete and incomplete resection was not
evaluated in the follow-up period. Over the years, many different surgeons have
participated in these operations in our department. Although these tumors are
rare; after the diagnosis, especially in patients with cardiac sarcomas, the
realization of these operation performing of these operations by experienced
surgeons in a multidisciplinary approach may improve patient outcomes.</p></sec></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>Primary cardiac tumors have many different histopathological types in benign and
malignant groups. Complete resection of the tumor, whenever possible, is the main
goal of surgery. Surgical resection of benign cardiac tumors is safe, usually
curative and provides excellent long-term prognosis. On the contrary, malignant
cardiac tumors still remain highly lethal. Adjuvant therapy may increase survival
rates in primary cardiac lymphoma.</p><table-wrap id="t6" orientation="portrait" position="anchor"><table frame="hsides" rules="groups"><colgroup span="1"><col width="10%" span="1"/><col width="90%" span="1"/></colgroup><thead><tr><th align="left" colspan="2" rowspan="1">Authors' roles &#x00026; responsibilities</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">KB</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to the
conception or design of the work; or the acquisition, analysis, or
interpretation of data for the work; final approval of the version
to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">AA</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to the
conception or design of the work; or the acquisition, analysis, or
interpretation of data for the work; final approval of the version
to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">AAD</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to the
conception or design of the work; or the acquisition, analysis, or
interpretation of data for the work; final approval of the version
to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">B&#x000c7;</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to the
conception or design of the work; or the acquisition, analysis, or
interpretation of data for the work; final approval of the version
to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MA</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to the
conception or design of the work; or the acquisition, analysis, or
interpretation of data for the work; final approval of the version
to be published</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MAT</td><td align="left" valign="top" rowspan="1" colspan="1">Substantial contributions to the
conception or design of the work; or the acquisition, analysis, or
interpretation of data for the work; final approval of the version
to be published</td></tr></tbody></table></table-wrap></sec></body><back><fn-group><fn fn-type="other"><p>This study was carried out at the Cardiovascular Surgery Department, Bagcilar
Research and Training Hospital, Istanbul, Turkey.</p></fn><fn fn-type="COI-statement"><p>No conflict of interest.</p></fn></fn-group><fn-group><fn fn-type="financial-disclosure"><p>No financial support.</p></fn><fn fn-type="COI-statement"><p>No conflict of interest.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abraham</surname><given-names>KP</given-names></name><name><surname>Reddy</surname><given-names>V</given-names></name><name><surname>Gattuso</surname><given-names>P</given-names></name></person-group><article-title>Neoplasms metastatic to the heart: review of 3314 consecutive
autopsies</article-title><source>Am J Cardiovasc Pathol</source><year>1990</year><volume>3</volume><issue>3</issue><fpage>195</fpage><lpage>198</lpage><pub-id pub-id-type="pmid">2095826</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elbardissi</surname><given-names>AW</given-names></name><name><surname>Dearani</surname><given-names>JA</given-names></name><name><surname>Daly</surname><given-names>RC</given-names></name><name><surname>Mullany</surname><given-names>CJ</given-names></name><name><surname>Orszulak</surname><given-names>TA</given-names></name><name><surname>Puga</surname><given-names>FJ</given-names></name><etal/></person-group><article-title>Survival after resection of primary cardiac tumors: a 48-year
experience</article-title><source>Circulation</source><year>2008</year><volume>118</volume><issue>14</issue><supplement>Suppl</supplement><fpage>S7</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">18824772</pub-id></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grebenc</surname><given-names>ML</given-names></name><name><surname>Rosado de Christenson</surname><given-names>ML</given-names></name><name><surname>Burke</surname><given-names>AP</given-names></name><name><surname>Green</surname><given-names>CE</given-names></name><name><surname>Galvin</surname><given-names>JR</given-names></name></person-group><article-title>Primary cardiac and pericardial neoplasms: radiologic-pathologic
correlation</article-title><source>Radiographics</source><year>2000</year><volume>20</volume><issue>4</issue><fpage>1073</fpage><lpage>1103</lpage><pub-id pub-id-type="pmid">10903697</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kamiya</surname><given-names>H</given-names></name><name><surname>Yasuda</surname><given-names>T</given-names></name><name><surname>Nagamine</surname><given-names>H</given-names></name><name><surname>Sakakibara</surname><given-names>N</given-names></name><name><surname>Nishida</surname><given-names>S</given-names></name><name><surname>Kawasuji</surname><given-names>M</given-names></name><etal/></person-group><article-title>Surgical treatment of primary cardiac tumors: 28 years'
experience in Kanazawa University Hospital</article-title><source>Jpn Circ J</source><year>2001</year><volume>65</volume><issue>4</issue><fpage>315</fpage><lpage>319</lpage><pub-id pub-id-type="pmid">11316130</pub-id></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Padalino</surname><given-names>MA</given-names></name><name><surname>Vida</surname><given-names>VL</given-names></name><name><surname>Boccuzzo</surname><given-names>G</given-names></name><name><surname>Tonello</surname><given-names>M</given-names></name><name><surname>Sarris</surname><given-names>GE</given-names></name><name><surname>Berggren</surname><given-names>H</given-names></name><etal/></person-group><article-title>Surgery for primary cardiac tumors in children: early and late
results in a multicenter European Congenital Heart Surgeons Association
study</article-title><source>Circulation</source><year>2012</year><volume>126</volume><issue>1</issue><fpage>22</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">22626745</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uzun</surname><given-names>O</given-names></name><name><surname>Wilson</surname><given-names>DG</given-names></name><name><surname>Vujanic</surname><given-names>GM</given-names></name><name><surname>Parsons</surname><given-names>JM</given-names></name><name><surname>De Giovanni</surname><given-names>JV</given-names></name></person-group><article-title>Cardiac tumors in children</article-title><source>Orphanet J Rare Dis</source><year>2007</year><volume>2</volume><fpage>11</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">17331235</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>L</given-names></name><name><surname>Wu</surname><given-names>L</given-names></name><name><surname>Fang</surname><given-names>H</given-names></name><name><surname>Han</surname><given-names>B</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Ma</surname><given-names>X</given-names></name><etal/></person-group><article-title>Identification and clinical course of 166 pediatric cardiac
tumors</article-title><source>Eur J Pediatr</source><year>2017</year><volume>176</volume><issue>2</issue><fpage>253</fpage><lpage>260</lpage><pub-id pub-id-type="pmid">28074279</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anastacio</surname><given-names>MM</given-names></name><name><surname>Moon</surname><given-names>MR</given-names></name><name><surname>Damiano Jr</surname><given-names>RJ</given-names></name><name><surname>Pasque</surname><given-names>MK</given-names></name><name><surname>Maniar</surname><given-names>HS</given-names></name><name><surname>Lawton</surname><given-names>JS</given-names></name></person-group><article-title>Surgical experience with cardiac papillary fibroelastoma over a
15-year period</article-title><source>Ann Thorac Surg</source><year>2012</year><volume>94</volume><issue>2</issue><fpage>547</fpage><lpage>541</lpage></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoashi</surname><given-names>T</given-names></name><name><surname>Florentine</surname><given-names>MS</given-names></name><name><surname>Gordon</surname><given-names>D</given-names></name><name><surname>Ohye</surname><given-names>RG</given-names></name></person-group><article-title>Cardiac papillary fibroelastoma presenting as chorea in
childhood</article-title><source>Pediatr Cardiol</source><year>2009</year><volume>30</volume><issue>7</issue><fpage>995</fpage><lpage>997</lpage><pub-id pub-id-type="pmid">19458993</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ikegami</surname><given-names>H</given-names></name><name><surname>Andrei</surname><given-names>AC</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>McCarthy</surname><given-names>PM</given-names></name><name><surname>Malaisrie</surname><given-names>SC</given-names></name></person-group><article-title>Papillary fibroelastoma of the aortic valve: analysis of 21
cases, including a presentation with cardiac arrest</article-title><source>Tex Heart Ins J</source><year>2015</year><volume>42</volume><issue>2</issue><fpage>131</fpage><lpage>135</lpage></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gowda</surname><given-names>RM</given-names></name><name><surname>Khan</surname><given-names>IA</given-names></name><name><surname>Nair</surname><given-names>CK</given-names></name><name><surname>Mehta</surname><given-names>NJ</given-names></name><name><surname>Vasavada</surname><given-names>BC</given-names></name><name><surname>Sacchi</surname><given-names>TJ</given-names></name></person-group><article-title>Cardiac papillary fibroelastoma: a comprehensive analysis of 725
cases</article-title><source>Am Heart J</source><year>2003</year><volume>146</volume><issue>3</issue><fpage>404</fpage><lpage>410</lpage><pub-id pub-id-type="pmid">12947356</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delmo Walter</surname><given-names>EM</given-names></name><name><surname>Javier</surname><given-names>MF</given-names></name><name><surname>Sander</surname><given-names>F</given-names></name><name><surname>Hartmann</surname><given-names>B</given-names></name><name><surname>Ekkernkamp</surname><given-names>A</given-names></name><name><surname>Hetzer</surname><given-names>R</given-names></name></person-group><article-title>Primary cardiac tumors in &#x00131;nfants and children: surgical
strategy and long-term outcome</article-title><source>Ann Thorac Surg</source><year>2016</year><volume>102</volume><issue>6</issue><fpage>2062</fpage><lpage>2069</lpage><pub-id pub-id-type="pmid">27344282</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirma</surname><given-names>C</given-names></name><name><surname>Izgi</surname><given-names>A</given-names></name><name><surname>Yakut</surname><given-names>C</given-names></name><name><surname>Guler</surname><given-names>M</given-names></name><name><surname>Can</surname><given-names>M</given-names></name><name><surname>Zemheri</surname><given-names>E</given-names></name></person-group><article-title>Primary left ventricular angiomatosis: first description of a
rare vascular tumor in the heart</article-title><source>Int Heart J</source><year>2006</year><volume>47</volume><issue>3</issue><fpage>469</fpage><lpage>474</lpage><pub-id pub-id-type="pmid">16823253</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simpson</surname><given-names>L</given-names></name><name><surname>Kumar</surname><given-names>SK</given-names></name><name><surname>Okuno</surname><given-names>SH</given-names></name><name><surname>Schaff</surname><given-names>HV</given-names></name><name><surname>Porrata</surname><given-names>LF</given-names></name><name><surname>Buckner</surname><given-names>JC</given-names></name><etal/></person-group><article-title>Malignant primary cardiac tumors: review of a single institution
experience</article-title><source>Cancer</source><year>2008</year><volume>112</volume><issue>11</issue><fpage>2440</fpage><lpage>2446</lpage><pub-id pub-id-type="pmid">18428209</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bakaeen</surname><given-names>FG</given-names></name><name><surname>Jaroszewski</surname><given-names>DE</given-names></name><name><surname>Rice</surname><given-names>DC</given-names></name><name><surname>Walsh</surname><given-names>GL</given-names></name><name><surname>Vaporciyan</surname><given-names>AA</given-names></name><name><surname>Swisher</surname><given-names>SS</given-names></name><etal/></person-group><article-title>Outcomes after surgical resection of cardiac sarcoma in the
multimodality treatment era</article-title><source>J Thorac Cardiovasc Surg</source><year>2009</year><volume>137</volume><issue>6</issue><fpage>1454</fpage><lpage>1460</lpage><pub-id pub-id-type="pmid">19464464</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shapira</surname><given-names>OM</given-names></name><name><surname>Korach</surname><given-names>A</given-names></name><name><surname>Izhar</surname><given-names>U</given-names></name><name><surname>Koler</surname><given-names>T</given-names></name><name><surname>Wald</surname><given-names>O</given-names></name><name><surname>Ayman</surname><given-names>M</given-names></name><etal/></person-group><article-title>Radical multidisciplinary approach to primary cardiac
sarcomas</article-title><source>Eur J Cardiothorac Surg</source><year>2013</year><volume>44</volume><issue>2</issue><fpage>330</fpage><lpage>335</lpage><pub-id pub-id-type="pmid">23392107</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Look Hong</surname><given-names>NJ</given-names></name><name><surname>Pandalai</surname><given-names>PK</given-names></name><name><surname>Hornick</surname><given-names>JL</given-names></name><name><surname>Shekar</surname><given-names>PS</given-names></name><name><surname>Harmon</surname><given-names>DC</given-names></name><name><surname>Chen</surname><given-names>YL</given-names></name><etal/></person-group><article-title>Cardiac angiosarcoma management and outcomes: 20-year
single-institution experience</article-title><source>Ann Surg Oncol</source><year>2012</year><volume>19</volume><issue>8</issue><fpage>2707</fpage><lpage>2715</lpage><pub-id pub-id-type="pmid">22476752</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blackmon</surname><given-names>SH</given-names></name><name><surname>Reardon</surname><given-names>MJ</given-names></name></person-group><article-title>Surgical treatment of primary cardiac sarcomas</article-title><source>Tex Heart Inst J</source><year>2009</year><volume>36</volume><issue>5</issue><fpage>451</fpage><lpage>452</lpage><pub-id pub-id-type="pmid">19876427</pub-id></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lestuzzi</surname><given-names>C</given-names></name></person-group><article-title>Primary tumors of the heart</article-title><source>Curr Opin Cardiol</source><year>2016</year><volume>31</volume><issue>6</issue><fpage>593</fpage><lpage>598</lpage><pub-id pub-id-type="pmid">27652810</pub-id></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramlawi</surname><given-names>B</given-names></name><name><surname>Leja</surname><given-names>MJ</given-names></name><name><surname>Abu Saleh</surname><given-names>WK</given-names></name><name><surname>Al Jabbari</surname><given-names>O</given-names></name><name><surname>Benjamin</surname><given-names>R</given-names></name><name><surname>Ravi</surname><given-names>V</given-names></name><etal/></person-group><article-title>Surgical treatment of primary cardiac sarcomas: review of a
single-&#x00131;nstitution experience</article-title><source>Ann Thorac Surg</source><year>2016</year><volume>101</volume><issue>2</issue><fpage>698</fpage><lpage>702</lpage><pub-id pub-id-type="pmid">26476808</pub-id></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soon</surname><given-names>G</given-names></name><name><surname>Ow</surname><given-names>GW</given-names></name><name><surname>Chan</surname><given-names>HL</given-names></name><name><surname>Ng</surname><given-names>SB</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name></person-group><article-title>Primary cardiac diffuse large B-cell lymphoma in immunocompetent
patients: clinical, histologic, immunophenotypic, and genotyphic features of
3 cases</article-title><source>Ann Diagn Pathol</source><year>2016</year><volume>24</volume><fpage>40</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">27649953</pub-id></element-citation></ref><ref id="r22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petrich</surname><given-names>A</given-names></name><name><surname>Cho</surname><given-names>SI</given-names></name><name><surname>Billett</surname><given-names>H</given-names></name></person-group><article-title>Primary cardiac lymphoma: an analysis of presentation, treatment,
and outcome patterns</article-title><source>Cancer</source><year>2011</year><volume>117</volume><issue>3</issue><fpage>581</fpage><lpage>589</lpage><pub-id pub-id-type="pmid">20922788</pub-id></element-citation></ref><ref id="r23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Motomatsu</surname><given-names>Y</given-names></name><name><surname>Oishi</surname><given-names>Y</given-names></name><name><surname>Matsunaga</surname><given-names>S</given-names></name><name><surname>Onitsuka</surname><given-names>H</given-names></name><name><surname>Yamamoto</surname><given-names>H</given-names></name><name><surname>Zaitsu</surname><given-names>E</given-names></name><etal/></person-group><article-title>Primary cardiac T-cell lymphoma localized in the mitral
valv</article-title><source>Ann Thorac Surg</source><year>2016</year><volume>101</volume><issue>6</issue><fpage>2363</fpage><lpage>2365</lpage><pub-id pub-id-type="pmid">27211945</pub-id></element-citation></ref><ref id="r24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butany</surname><given-names>J</given-names></name><name><surname>Nair</surname><given-names>V</given-names></name><name><surname>Naseemuddin</surname><given-names>A</given-names></name><name><surname>Nair</surname><given-names>GM</given-names></name><name><surname>Catton</surname><given-names>C</given-names></name><name><surname>Yau</surname><given-names>T</given-names></name></person-group><article-title>Cardiac tumours: diagnosis and management</article-title><source>Lancet Oncol</source><year>2005</year><volume>6</volume><issue>4</issue><fpage>219</fpage><lpage>228</lpage><pub-id pub-id-type="pmid">15811617</pub-id></element-citation></ref><ref id="r25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gyoten</surname><given-names>T</given-names></name><name><surname>Doi</surname><given-names>T</given-names></name><name><surname>Nagura</surname><given-names>S</given-names></name><name><surname>Yamashita</surname><given-names>A</given-names></name><name><surname>Fukahara</surname><given-names>K</given-names></name><name><surname>Kotoh</surname><given-names>K</given-names></name><etal/></person-group><article-title>Primary cardiac malignant lymphoma: survival for 13 years after
surgical resection and adjuvant chemotherapy</article-title><source>Ann Thorac Surg</source><year>2015</year><volume>99</volume><issue>3</issue><fpage>1060</fpage><lpage>1062</lpage><pub-id pub-id-type="pmid">25742830</pub-id></element-citation></ref></ref-list></back></article>